Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 21, 2001
Monocyte chemoattractant protein-1-dependent increase of V alpha 14 NKT cells in lungs and their roles in Th1 response and host defense in cryptococcal infection
K Kawakami, Y Kinjo, K Uezu, et al.
FEMS Immunology and Medical Microbiology
|
February 23, 2000
Involvement of endogenously synthesized interleukin (IL)-18 in the protective effects of IL-12 against pulmonary infection with Cryptococcus neoformans in mice
K Kawakami, M H Qureshi, T Zhang, et al.
Microbiology and Immunology
|
February 28, 2001
Circulating soluble CD4 directly prevents host resistance and delayed-type hypersensitivity response to Cryptococcus neoformans in mice
K Kawakami, Y Koguchi, M H Qureshi, et al.
Internal Medicine (Tokyo, Japan)
|
May 4, 1999
Concurrent infection with Legionella pneumophila and Pneumocystis carinii in a patient with adult T cell leukemia
N Arakaki, F Higa, M Tateyama, et al.
Infection and Immunity
|
October 13, 2001
Enhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis
K Kawakami, Y Kinjo, S Yara, et al.
FEMS Microbiology Letters
|
April 26, 2000
Reduced host resistance and Th1 response to Cryptococcus neoformans in interleukin-18 deficient mice
K Kawakami, Y Koguchi, M H Qureshi, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 6, 2000
IL-18 contributes to host resistance against infection with Cryptococcus neoformans in mice with defective IL-12 synthesis through induction of IFN-gamma production by NK cells
K Kawakami, Y Koguchi, M H Qureshi, et al.
ESMO Open
|
June 7, 2023
Regorafenib in patients with relapsed advanced or metastatic chordoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre phase II study
A Le Cesne, C Chevreau, C Perrin, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 21, 2001
Monocyte chemoattractant protein-1-dependent increase of V alpha 14 NKT cells in lungs and their roles in Th1 response and host defense in cryptococcal infection
K Kawakami, Y Kinjo, K Uezu, et al.
FEMS Immunology and Medical Microbiology
|
February 23, 2000
Involvement of endogenously synthesized interleukin (IL)-18 in the protective effects of IL-12 against pulmonary infection with Cryptococcus neoformans in mice
K Kawakami, M H Qureshi, T Zhang, et al.
Microbiology and Immunology
|
February 28, 2001
Circulating soluble CD4 directly prevents host resistance and delayed-type hypersensitivity response to Cryptococcus neoformans in mice
K Kawakami, Y Koguchi, M H Qureshi, et al.
Internal Medicine (Tokyo, Japan)
|
May 4, 1999
Concurrent infection with Legionella pneumophila and Pneumocystis carinii in a patient with adult T cell leukemia
N Arakaki, F Higa, M Tateyama, et al.
Infection and Immunity
|
October 13, 2001
Enhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis
K Kawakami, Y Kinjo, S Yara, et al.
FEMS Microbiology Letters
|
April 26, 2000
Reduced host resistance and Th1 response to Cryptococcus neoformans in interleukin-18 deficient mice
K Kawakami, Y Koguchi, M H Qureshi, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 6, 2000
IL-18 contributes to host resistance against infection with Cryptococcus neoformans in mice with defective IL-12 synthesis through induction of IFN-gamma production by NK cells
K Kawakami, Y Koguchi, M H Qureshi, et al.
ESMO Open
|
June 7, 2023
Regorafenib in patients with relapsed advanced or metastatic chordoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre phase II study
A Le Cesne, C Chevreau, C Perrin, et al.
Page
of 2